These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11307783)

  • 21. Successful elimination of significant arrhythmia burden with flecainide in an adolescent with long QT syndrome type 3.
    Kilinc OU; Tuzcu V
    Congenit Heart Dis; 2012; 7(4):E42-5. PubMed ID: 22129298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome.
    Brugada R; Brugada P; Brugada J
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S115-8. PubMed ID: 16934827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K; Sredniawa B; Pasyk S
    Przegl Lek; 2002; 59(7):523-6. PubMed ID: 12516242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brugada syndrome].
    Veiser T; Laurent G; Wolf JE
    Cas Lek Cesk; 2005; 144(4):219-23. PubMed ID: 15945478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
    Dautova Y; Zhang Y; Grace AA; Huang CL
    Exp Physiol; 2010 Oct; 95(10):994-1007. PubMed ID: 20621962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long QT Syndrome.
    Goldenberg I; Zareba W; Moss AJ
    Curr Probl Cardiol; 2008 Nov; 33(11):629-94. PubMed ID: 18835466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
    Hothi SS; Booth SW; Sabir IN; Killeen MJ; Simpson F; Zhang Y; Grace AA; Huang CL
    Prog Biophys Mol Biol; 2008; 98(2-3):267-80. PubMed ID: 19351517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood.
    Beaufort-Krol GC; van den Berg MP; Wilde AA; van Tintelen JP; Viersma JW; Bezzina CR; Bink-Boelkens MT
    J Am Coll Cardiol; 2005 Jul; 46(2):331-7. PubMed ID: 16022964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From gene to disease; ion channel proteins and the long QT syndrome].
    Wilde AA; van Langen IM
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2205-7. PubMed ID: 11103258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of congenital long QT syndrome and Brugada syndrome.
    Shimizu W
    Future Cardiol; 2008 Jul; 4(4):379-89. PubMed ID: 19804318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.
    Wilde AA; Moss AJ; Kaufman ES; Shimizu W; Peterson DR; Benhorin J; Lopes C; Towbin JA; Spazzolini C; Crotti L; Zareba W; Goldenberg I; Kanters JK; Robinson JL; Qi M; Hofman N; Tester DJ; Bezzina CR; Alders M; Aiba T; Kamakura S; Miyamoto Y; Andrews ML; McNitt S; Polonsky B; Schwartz PJ; Ackerman MJ
    Circulation; 2016 Sep; 134(12):872-82. PubMed ID: 27566755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case report of a young patient with both Brugada and long QT3 syndrome: between the hammer and the anvil.
    Abu Dogoshh A; Konstantino Y; Haim M
    Eur Heart J Case Rep; 2021 Mar; 5(3):ytab053. PubMed ID: 34708182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Therapy Based on the Genotype in a Malignant Form of Long QT3, Carrying the V411M Mutation.
    Blich M; Khoury A; Suleiman M; Lorber A; Gepstein L; Boulous M
    Int Heart J; 2019 Jul; 60(4):979-982. PubMed ID: 31257342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia.
    Clancy CE; Rudy Y
    Nature; 1999 Aug; 400(6744):566-9. PubMed ID: 10448858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
    Peters CH; Abdelsayed M; Ruben PC
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):77-88. PubMed ID: 26713557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal long QT syndrome type 3 predicted by positive lidocaine challenge.
    Howley LW; DI Maria M; Bailey A; Schaffer MS
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):377-9. PubMed ID: 19793370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.
    Veldkamp MW; Viswanathan PC; Bezzina C; Baartscheer A; Wilde AA; Balser JR
    Circ Res; 2000 May; 86(9):E91-7. PubMed ID: 10807877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.